Option Care Health (NASDAQ:OPCH) Reaches New 12-Month High – Still a Buy?

Option Care Health, Inc. (NASDAQ:OPCH) reached a new 52-week high during trading on Monday . The company traded as high as $34.49 and last traded at $34.43, with a volume of 489599 shares. The stock had previously closed at $33.50.

Analyst Ratings Changes

OPCH has been the subject of a number of analyst reports. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $38.00 to $27.00 in a research note on Monday, November 4th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. UBS Group started coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target for the company. Barrington Research increased their target price on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price target for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $32.88.

Option Care Health Stock Up 1.4 %

The firm has a market capitalization of $5.78 billion, a price-to-earnings ratio of 28.54, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The business has a fifty day moving average price of $28.70 and a two-hundred day moving average price of $28.06. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insiders Place Their Bets

In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.64% of the stock is owned by insiders.

Hedge Funds Weigh In On Option Care Health

Institutional investors have recently modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of Option Care Health by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company’s stock worth $448,118,000 after purchasing an additional 75,313 shares during the period. Wellington Management Group LLP increased its holdings in shares of Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock valued at $425,143,000 after purchasing an additional 8,400,208 shares in the last quarter. FMR LLC grew its position in Option Care Health by 134.0% during the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after buying an additional 4,304,896 shares during the period. Westfield Capital Management Co. LP increased its holdings in Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after buying an additional 599,589 shares in the last quarter. Finally, State Street Corp lifted its position in shares of Option Care Health by 1.4% during the 3rd quarter. State Street Corp now owns 6,257,172 shares of the company’s stock valued at $195,849,000 after acquiring an additional 83,395 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.